JPRN-UMIN000014550
Not Yet Recruiting
N/A
To calculate new biomarkers and its efficacy of the progresion for non-alcoholic fatty liver disease patients. - To calculate new biomarkers and its efficacy of the progresion for non-alcoholic fatty liver disease patients.
Shinshu University of Medicine0 sites600 target enrollmentJuly 15, 2014
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- non-alcoholic fatty liver disease (NAFLD)
- Sponsor
- Shinshu University of Medicine
- Enrollment
- 600
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
Completed
N/A
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
Completed
N/A
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000010140Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences216
Recruiting
N/A
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseJPRN-UMIN000014093Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences512
Completed
N/A
Study for new biomarker development in the prediction of renal anemia progression in chronic kidney diseaseJPRN-UMIN000008699Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences90